Serological Immunoglobulin-Free Light Chain Profile in Myasthenia Gravis Patients
Background. Serological levels of free immunoglobulin light chains (FLCs), produced in excess of heavy chains during synthesis of immunoglobulins by plasma cells, can be considered a direct marker of B cell activity in different systemic inflammatory-autoimmune conditions and may represent a useful...
Saved in:
Main Authors: | Umberto Basile, Mariapaola Marino, Cecilia Napodano, Krizia Pocino, Paolo Emilio Alboini, Francesca Gulli, Amelia Evoli, Carlo Provenzano, Emanuela Bartoccioni |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2018/9646209 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Defects of CTLA-4 Are Associated with Regulatory T Cells in Myasthenia Gravis Implicated by Intravenous Immunoglobulin Therapy
by: Wenhua Xu, et al.
Published: (2020-01-01) -
Severe Preeclampsia in the Setting of Myasthenia Gravis
by: Adam J. Lake, et al.
Published: (2017-01-01) -
Myasthenia Gravis Masquerading as Status Asthmaticus
by: Neha Pirwani, et al.
Published: (2021-01-01) -
New treatment options for generalized myasthenia gravis
by: Antanas Vaitkus, et al.
Published: (2024-02-01) -
Autoantibodies in myasthenia gravis: cluster analysis and clinical correlations
by: Xupeng Sun, et al.
Published: (2025-02-01)